The effect of lifestyle modification and glycemic control on the efficiency of sildenafil citrate in patients with erectile dysfunction due to type-2 diabetes mellitus

References

• Hatzimouratidis K, Eardley I, Giuliano F, et al. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. European Association of Urology; 2014. Available from: http://uroweb.org/wp-content/uploads/EAU-Guidelines-2015-Male-Sexual-Dysfunction_LR.pdf[last accessed 22 Jul 2015]
   Google Scholar
• El-Sakka AI. Association of risk factors and medical comorbidities with male sexual dysfunctions. J Sex Med 2007;4:1691–700
   PubMed Web of Science ®Google Scholar
• Lewis RW. Epidemiology of erectile dysfunction. Urol Clin North Am 2001;28:209–16
   PubMed Web of Science ®Google Scholar
• Satman I, Yilmaz T, Sengül A, et al. The TURDEP Group, population-based study of diabetes and related risk characteristics in Turkey. Diabetes Care 2002;25:1551–6
   PubMed Web of Science ®Google Scholar
• Derby CA, Mohr BA, Goldstein I, et al. Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk? Urology 2000;56:302–6
   PubMed Web of Science ®Google Scholar
• Yokoyama Y, Barnard ND, Levin SM, Watanabe M. Vegetarian diets and glycemic control in diabetes: a systematic review and meta-analysis. Cardiovasc Diagn Ther 2014;4:373–82
   PubMedGoogle Scholar
• American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004;27:5–14
   PubMedGoogle Scholar
• Lu CC, Jiann BP, Sun CC, et al. Association of glycemic control with risk of erectile dysfunction in men with type 2 diabetes. J Sex Med 2009;6:1719–28
   PubMed Web of Science ®Google Scholar
• Rosen RC, Riley A, Wagner G, et al. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997;49:822–30
   PubMed Web of Science ®Google Scholar
• Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994;151:54–61
   PubMed Web of Science ®Google Scholar
• Akkus E, Kadioglu A, Esen A, et al. Prevalence and correlates of erectile dysfunction in Turkey: a population-based study. Eur Urol 2002;41:298–304
   PubMed Web of Science ®Google Scholar
• Braun M, Wassmer G, Klotz T, et al. Epidemiology of erectile dysfunction: results of the “Cologne Male Survey”. Int J Impot Res 2000;12:305–11
   PubMed Web of Science ®Google Scholar
• Churdchomjan W, Kheolamai P, Manochantr S, et al. Comparison of endothelial progenitor cell function in type 2 diabetes with good and poor glycemic control. BMC Endocr Disord 2010;7:10–15
   Google Scholar
• Makimattilla S, Yki-Jarvinen H. Endothelial dysfunction in human diabetes. Curr Diab Rep 2002;2:26–36
   PubMedGoogle Scholar
• Chitaley K. Type 1 and type 2 diabetic-erectile dysfunction: same diagnosis (ICD-9), different disease? J Sex Med 2009;6:262–8
   PubMed Web of Science ®Google Scholar
• El Saka AI. Efficacy of sildenafil citrate in treatment of erectile dysfunction: effect of type 2 diabetes. Eur Urol 2004;46:503–9
   PubMed Web of Science ®Google Scholar
• Romeo JH, Seftel AD, Madhun ZT, Aron DC. Sexual function in men with diabetes type 2: association with glycemic control. J Urol 2000;163:788–91
   PubMed Web of Science ®Google Scholar
• Esposito K, Giugliano F, Di Palo C, et al. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA 2004;291:2978–84
   PubMed Web of Science ®Google Scholar
• De Berardis G, Pellegrini F, Franciosi M, et al. Clinical and psychological predictors of incidence of self-reported erectile dysfunction in patients with type 2 diabetes. J Urol 2007;77:252–7
   Web of Science ®Google Scholar
• Matfin G, Jawa A, Fonseca VA. Erectile dysfunction: interrelationship of metabolic syndrome. Curr Diabetes Rep 2005;5:64–9
   PubMedGoogle Scholar
• Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405–12
   PubMed Web of Science ®Google Scholar
• Glina S, Sharlip ID, Hellstrom WJ. Modifying risk factors to prevent and treat erectile dysfunction. J Sex Med 2013;10:115–19
   PubMed Web of Science ®Google Scholar
• Yaman Ö, Akand M, Gürsoy A, et al. The effect of diabetes mellitus treatment and good glycemic control on the erectile function in men with diabetes mellitus-induced erectile dysfunction: a pilot study. J Sex Med 2006;3:344–8
   PubMed Web of Science ®Google Scholar
• Esposito K, Giugliano F, Maiorino MI, Giugliano D. Dietary factors, Mediterranean diet and erectile dysfunction. J Sex Med 2010;7:2338–45
   PubMed Web of Science ®Google Scholar
• Rhoden EL, Riberio EP, Riedner CE, et al. Glycosylated heamoglobin levels and the severity of erectile function in diabetic men. BJU Int 2005;95:615–17
   PubMed Web of Science ®Google Scholar
• Khatana SA, Taveria TH, Miner MM, et al. Does cardiovascular risk reduction alleviate erectile dysfunction in men with type 2 diabetes mellitus? Int J Impot Res 2008;20:501–6
   PubMed Web of Science ®Google Scholar
• Spijkermen AM, Henry RM, Dekker JM. Prevalence of microvascular disease amongst type 2 diabetic patients detected by targeted screening and patients newly diagnosed in general practice: the Hoorn Screening study. J Intern Med 2004;256:429–36
   PubMed Web of Science ®Google Scholar
• Wolczak MK, Lakhmandale N, Hodge MB, Guay AT. Prevalence of cardiovascular risk factor in erectile dysfunction. J Gend Specif Med 2002;5:19–24
   Google Scholar
• Aslan Y, Sezgin T, Tuncel A, et al. Is type 2 diabetes mellitus a cause of severe erectile dysfunction in patients with metabolic syndrome. Urology 2009;74:561–4
   PubMed Web of Science ®Google Scholar
• Wing RR, Rosen RC, Fava JL, et al. Effects of weight loss intervention on erectile function in older men with type 2 diabetes in the Look AHEAD trial. J Sex Med 2010;7:156–65
   PubMed Web of Science ®Google Scholar
• Wang C, Nieschlag E, Swerdloff RS, et al. ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male 2009;12:5–12
   PubMed Web of Science ®Google Scholar
• Lunenfeld B, Mskhalaya G, Kalinchenko S, Tishova Y. Recommendations on the diagnosis, treatment and monitoring of late-onset hypogonadism in men – a suggested update. Aging Male 2013;16:143–50
   PubMed Web of Science ®Google Scholar
• Makhsida N, Shah J, Yan G, et al. Hypogonadism and metabolic syndrome: implications for testosteron therapy. J Urol 2005;174:827–34
   PubMed Web of Science ®Google Scholar
• Almehmadi Y, Yassin DJ, Yassin AA. Erectile dysfunction is a prognostic indicator of comorbidities in men with late onset hypogonadism. Aging Male 2015:1–9. [Epub ahead of print]. doi: 10.3109/13685538.2015.1046044
   PubMed Web of Science ®Google Scholar
• Saad F, Yassin A, Almehmadi Y, et al. Effects of long-term testosterone replacement therapy, with a temporary intermission, on glycemic control of nine hypogonadal men with type 1 diabetes mellitus – a series of case reports. Aging Male 2015:1–5. [Epub ahead of print]. doi: 10.3109/13685538.2015.1034687
   PubMed Web of Science ®Google Scholar